Maloberti Renaud Bertrand 4
4 · ENDRA Life Sciences Inc. · Filed Dec 21, 2020
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Sale
Common Stock
2020-12-17$0.73/sh−25,000$18,250→ 41,580 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.75, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F3]Includes unvested restricted stock units.